ADMETSYS

Autonomously regulates patient glucose with zero clinician intervention, directly infusing continuously-optimized insulin and dextrose therapy... Cartridge-based design with 4 analytes: blood glucose, lactate, temperature, hematocrit (expandable to 20 analytes), providing up to 7 days of continuous biosensing... The future of critical care is high-precision automation Adaptive to each individual patient Automatically implementing goals set by the clinician Repeatably, economically, at scale

Also known as: Admetsys Corporation